Market Overview

Goldman Drops McKesson To Neutral, Sees Limited Upside

Related MCK
Lightning Round: Jim Cramer Advises Viewers On Chegg, Opko Health And More
Should Value Investors Consider McKesson (MCK) Stock?
The Vetr community has upgraded $MCK to 4.5-Stars. (Vetr)

McKesson Corporation (NYSE: MCK) has been generating weak earnings growth, and the lowering of brand pricing presents “an additional risk,” Goldman Sachs’ Robert P. Jones said in a report. He downgraded the rating on the company from Buy to Neutral, while reducing the price target from $210 to $189.

McKesson is facing headwinds from generics, M&A-related contract losses and currency. Against this backdrop, moderation in brand pricing represents an additional risk to earnings growth. Jones added that while these headwinds are already known, there is lack of compelling drivers for earnings, “outside of unknown M&A or capital deployment.”

Brand Pricing Issues Weigh

McKesson could end up with a shortfall of ~$60 million to its FY17 guidance in case brand inflation continued to be in the 7 percent range, rather than the 10 percent assumed in the guidance. “While MCK had been expecting modestly lower brand inflation, we think the slowdown could still present a headwind vs. expectations,” Jones mentioned.

Growth Outlook

McKesson’s core business is now expected to grow 5 percent in FY17, in-line with peers. The guidance implies double-digit Distribution EBIT growth in the back half of the year, which does not seem to incorporate the slowdown in brand pricing witnessed to date, the analyst commented.

The EPS estimates for FY17, FY18 and FY19 have been reduced from $13.75 to $13.57, from $15.05 to $14.81 and from $17.02 to $16.75, respectively.

Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!

Latest Ratings for MCK

May 2017JP MorganUpgradesNeutralOverweight
May 2017JefferiesInitiates Coverage OnHold
Apr 2017BarclaysReinstatesOverweight

View More Analyst Ratings for MCK
View the Latest Analyst Ratings

Posted-In: Goldman Sachs Robert P. JonesAnalyst Color Downgrades Price Target Analyst Ratings


Related Articles (MCK)

View Comments and Join the Discussion!